CNIO - Spanish National Cancer Research Centre
Lucas Friedman currently serves as a Data Manager at CNIO - Spanish National Cancer Research Centre since June 2023. Prior experience includes a Master's program in Bioinformatics at Máster de Bioinformática ENS-ISCIII, and a Data Analyst role at LendStreet Financial, where responsibilities encompassed automating reports and on-boarding financial collaborators. Lucas has also held positions in research and lab management at prestigious institutions such as Stanford University School of Medicine and Carnegie Mellon University, and has contributed to various internships at Bayer HealthCare, focusing on research techniques and data management. Educational qualifications include a Master's degree in Biomedical Engineering and a Bachelor of Science in Materials Science and Biomedical Engineering, both from Carnegie Mellon University.
This person is not in any teams
This person is not in any offices
CNIO - Spanish National Cancer Research Centre
The Spanish National Cancer Research Centre is a public institution of excellence committed to research, diagnosis and treatment for cancer. The CNIO currently houses 22 Research Groups, organised in 7 Scientific Programmes, plus 5 Clinical Research Unit(s) that work closely with several hospitals. These scientific groups are supported by 19 Core Units that provide state-of-the-art facilities and technical expertise. The CNIO also has an Experimental Therapeutics Programme leader in academic drug discovery. Since 2011, CNIO is recognised a one of the ‘Severo Ochoa’ Centres of Excellence by the Agencia Estatal de Investigación, Ministerio de Ciencia e Innovación -------------------------------- El Centro Nacional de Investigaciones Oncológicas (CNIO) es una institución pública española dedicada a la investigación, diagnóstico y tratamiento del cáncer. El CNIO cubre todo el recorrido de la I+D+i, desde la investigación básica hasta la clínica. Actualmente el CNIO tiene 22 Grupos de Investigación, organizados en 7 Programas Científicos, más 5 Unidades de Investigación Clínica que trabajan estrechamente con varios hospitales. En el CNIO hay 19 Unidades de Apoyo a la Investigación dotadas de las más modernas instalaciones y conocimientos técnicos. El CNIO también tiene un Programa de Terapias Experimentales de referencia en el descubrimiento de nuevos fármacos. Desde el 2011, el CNIO es uno de los Centros de Excelencia Severo Ochoa acreditados por la Agencia Estatal de Investigación, Ministerio de Ciencia e Innovación.